Xcellerated T CellsTM in Patients With Multiple Myeloma

NCT00078065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Xcellerated T Cells

Sponsor

Xcyte Therapies